New Delhi, Feb 10 (IANS) AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation (CDSCO) to sell and distribute Durvalumab solution for infusion used in cancer treatment for an additional indication.In its latest stock exchange filing, the drug company said that through this approval, “Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or rec…
Trending
- Governor: The Silent Saviour Review – Manoj Bajpayee’s Quiet Steel Lights Up a Riveting Financial Drama
- Habeebi Movie Review: A Heartfelt Tamil Period Romance That Celebrates Love, Legacy, and Tradition
- Heer Sara Movie Review: A Heartwarming Road Trip That Celebrates Friendship and Self-Discovery
- The Narmada Story Movie Review: A Gripping Crime Drama Powered by Stellar Performances
- Tumbadchi Manjula (2026) Movie Review: A Delightful Marathi Comedy That Wins Hearts With Its Village Charm
- Mollywood Times (2026) Review: Naslen Shines in a Bold, Bittersweet Love-Hate Letter to Malayalam Cinema
- Sannidhanam P.O. Movie Review: A Devotional Drama That Speaks From the Heart
- The Pyramid Scheme Exposes the Fast-Money Dreams Destroying Middle-Class India